- Home
- SKYE vs TWIN Comparison
SKYE vs TWIN Comparison
Compare SKYE & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- TWIN
- Stock Information
- Founded
- SKYE 2012
- TWIN 1918
- Country
- SKYE United States
- TWIN United States
- Employees
- SKYE N/A
- TWIN N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- TWIN Industrial Machinery/Components
- Sector
- SKYE Health Care
- TWIN Industrials
- Exchange
- SKYE Nasdaq
- TWIN Nasdaq
- Market Cap
- SKYE 115.9M
- TWIN 97.0M
- IPO Year
- SKYE N/A
- TWIN N/A
- Fundamental
- Price
- SKYE $3.98
- TWIN $9.41
- Analyst Decision
- SKYE Buy
- TWIN Strong Buy
- Analyst Count
- SKYE 6
- TWIN 1
- Target Price
- SKYE $16.60
- TWIN $12.00
- AVG Volume (30 Days)
- SKYE 2.2M
- TWIN 153.9K
- Earning Date
- SKYE 08-08-2025
- TWIN 08-14-2025
- Dividend Yield
- SKYE N/A
- TWIN 1.71%
- EPS Growth
- SKYE N/A
- TWIN N/A
- EPS
- SKYE N/A
- TWIN 0.29
- Revenue
- SKYE N/A
- TWIN $328,478,000.00
- Revenue This Year
- SKYE N/A
- TWIN $27.91
- Revenue Next Year
- SKYE N/A
- TWIN N/A
- P/E Ratio
- SKYE N/A
- TWIN $32.10
- Revenue Growth
- SKYE N/A
- TWIN 11.49
- 52 Week Low
- SKYE $1.14
- TWIN $6.16
- 52 Week High
- SKYE $7.47
- TWIN $14.98
- Technical
- Relative Strength Index (RSI)
- SKYE 60.88
- TWIN 62.89
- Support Level
- SKYE $3.65
- TWIN $9.19
- Resistance Level
- SKYE $4.75
- TWIN $9.77
- Average True Range (ATR)
- SKYE 0.71
- TWIN 0.51
- MACD
- SKYE 0.00
- TWIN 0.02
- Stochastic Oscillator
- SKYE 48.55
- TWIN 70.33
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.